Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypersensitivity Reaction

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 96 articles:
HTML format
Text format



Single Articles


    October 2017
  1. VAKHARIA PP, Chopra R, Sacotte R, Patel N, et al
    Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
    Br J Dermatol. 2017 Oct 19. doi: 10.1111/bjd.16078.
    PubMed     Text format     Abstract available


  2. EGEBERG A
    Cardiometabolic disease in atopic dermatitis: the heart of the matter.
    Br J Dermatol. 2017;177:898-899.
    PubMed     Text format    


    September 2017
  3. NAKAGAWA H, Nemoto O, Igarashi A, Nagata T, et al
    Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase 2, multi-centre, randomised, vehicle-controlled clinical study.
    Br J Dermatol. 2017 Sep 28. doi: 10.1111/bjd.16014.
    PubMed     Text format     Abstract available


  4. NOREN P, Hagstromer L, Alimohammadi M, Melin L, et al
    The positive effects of habit reversal treatment of scratching in children with atopic dermatitis: A randomised controlled study.
    Br J Dermatol. 2017 Sep 23. doi: 10.1111/bjd.16009.
    PubMed     Text format     Abstract available


  5. SIGURGEIRSSON B, Luger T
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.
    Br J Dermatol. 2017 Sep 21. doi: 10.1111/bjd.15849.
    PubMed     Text format    


  6. WEIDINGER S, Baurecht H, Schmitt J
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal.
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15827.
    PubMed     Text format     Abstract available


  7. DRUCKER AM, Eyerich K, de Bruin-Weller MS, Thyssen JP, et al
    Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.
    Br J Dermatol. 2017 Sep 2. doi: 10.1111/bjd.15928.
    PubMed     Text format     Abstract available


    August 2017
  8. CHARMAN C
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment.
    Br J Dermatol. 2017 Aug 31. doi: 10.1111/bjd.15848.
    PubMed     Text format    


  9. TSIANAKAS A, Luger TA, Radin A
    Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial.
    Br J Dermatol. 2017 Aug 27. doi: 10.1111/bjd.15905.
    PubMed     Text format     Abstract available


  10. HARRIS V, Smith SD
    Lifting the biofilm lid on the antibacterial and antibiofilm effects of sodium hypochlorite against Staphylococcus aureus in atopic dermatitis.
    Br J Dermatol. 2017;177:347-348.
    PubMed     Text format    


  11. SAMUEL RJ, Reynolds NJ
    Ustekinumab for severe atopic dermatitis: an important negative study.
    Br J Dermatol. 2017;177:339-341.
    PubMed     Text format    


    July 2017
  12. JACOB SE
    Percutaneous absorption risks in atopic dermatitis.
    Br J Dermatol. 2017;177:11-12.
    PubMed     Text format    


    June 2017
  13. LOWE AJ, Su JC, Allen KJ, Abramson MJ, et al
    A randomised trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitisation: The PEBBLES Pilot Study.
    Br J Dermatol. 2017 Jun 22. doi: 10.1111/bjd.15747.
    PubMed     Text format     Abstract available


  14. DRUCKER AM, Qureshi AA, Dummer TJB, Parker L, et al
    Atopic dermatitis and risk of hypertension, type-2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project.
    Br J Dermatol. 2017 Jun 15. doi: 10.1111/bjd.15727.
    PubMed     Text format     Abstract available


  15. BALATO A, Caiazzo G
    Mesenchymal stem cells participate to inflammatory skin process of atopic dermatitis.
    Br J Dermatol. 2017;176:1437-1438.
    PubMed     Text format    


  16. DRUCKER AM
    Treating moderate-to-severe atopic dermatitis: what do dermatologists do with limited evidence?
    Br J Dermatol. 2017;176:1441-1442.
    PubMed     Text format    


    May 2017
  17. CHOPRA R, Vakharia PP, Sacotte R, Patel N, et al
    Severity strata for EASI, mEASI, oSCORAD, SCORAD, ADSI and BSA in adolescents and adults with atopic dermatitis.
    Br J Dermatol. 2017 May 9. doi: 10.1111/bjd.15641.
    PubMed     Text format     Abstract available


  18. SIMONSEN AB, Johansen JD, Deleuran M, Mortz CG, et al
    Contact allergy in children with atopic dermatitis: a systematic review.
    Br J Dermatol. 2017 May 3. doi: 10.1111/bjd.15628.
    PubMed     Text format     Abstract available


    April 2017
  19. CHEOK S, Yee F, Ma JYS, Leow R, et al
    Prevalence and Descriptive Epidemiology of Atopic Dermatitis and Its Impact on Quality of Life in Singapore.
    Br J Dermatol. 2017 Apr 17. doi: 10.1111/bjd.15587.
    PubMed     Text format     Abstract available


  20. CHANSKY PB, Mittal L, Werth VP
    Dermatological evaluation in patients with skin of colour: the effect of erythema on outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:853-854.
    PubMed     Text format    


  21. NALDI L
    Finding a HOME for outcome measures in atopic dermatitis.
    Br J Dermatol. 2017;176:852-853.
    PubMed     Text format    


  22. WHITE IR
    Quantitative risk assessment and the burden of fragrance contact allergy.
    Br J Dermatol. 2017;176:860-861.
    PubMed     Text format    


    March 2017
  23. SAEKI H, Kabashima K, Tokura Y, Murata Y, et al
    Efficacy and Safety of Ustekinumab in Japanese Patients with Severe Atopic Dermatitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study.
    Br J Dermatol. 2017 Mar 24. doi: 10.1111/bjd.15493.
    PubMed     Text format     Abstract available


  24. ANDERSEN YM, Egeberg A, Gislason GH, Skov L, et al
    Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis.
    Br J Dermatol. 2017 Mar 23. doi: 10.1111/bjd.15489.
    PubMed     Text format     Abstract available


  25. RAMZY AG, Lammintausta K, Matura M, B Christensson J, et al
    Isothiocyanates are important as haptens in contact allergy to chloroprene rubber.
    Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15444.
    PubMed     Text format     Abstract available


    February 2017
  26. LI S, Villarreal M, Stewart S, Choi J, et al
    Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 28. doi: 10.1111/bjd.15409.
    PubMed     Text format     Abstract available


  27. ERIKSSON S, van der Plas MJ, Morgelin M, Sonesson A, et al
    Antibacterial and anti-biofilm effects of sodium hypochlorite against Staphylococcus aureus isolates derived from patients with atopic dermatitis.
    Br J Dermatol. 2017 Feb 26. doi: 10.1111/bjd.15410.
    PubMed     Text format     Abstract available


  28. CHANG J, Bilker WB, Hoffstad O, Margolis DJ, et al
    Cross-Sectional Comparisons of Patient-Reported Disease Control, Disease Severity, and Symptom Frequency in Children with Atopic Dermatitis.
    Br J Dermatol. 2017 Feb 24. doi: 10.1111/bjd.15403.
    PubMed     Text format     Abstract available


  29. DYBBOE R, Bandier J, Skov L, Engstrand L, et al
    The Role of the Skin Microbiome in Atopic Dermatitis: A Systematic Review.
    Br J Dermatol. 2017 Feb 16. doi: 10.1111/bjd.15390.
    PubMed     Text format     Abstract available


  30. PEETERS C, Herman A, Baeck M
    Donkey's milk allergy.
    Br J Dermatol. 2017 Feb 11. doi: 10.1111/bjd.15367.
    PubMed     Text format     Abstract available


  31. LINDBERG M, Soderquist B
    Atopic dermatitis and gut microbiota.
    Br J Dermatol. 2017;176:297-298.
    PubMed     Text format    


    January 2017
  32. MUGHAL AA
    What substances are allergenic and in whom?
    Br J Dermatol. 2017;176:14-15.
    PubMed     Text format    


  33. BISHNOI A, Parsad D, Vinay K, Kumaran MS, et al
    Phototherapy using narrowband ultraviolet B and psoralen plus ultraviolet A is beneficial in steroid-dependent antihistamine-refractory chronic urticaria: a randomized, prospective observer-blinded comparative study.
    Br J Dermatol. 2017;176:62-70.
    PubMed     Text format     Abstract available


  34. FLYNN A, Molony P, Keeting C, Cullen J, et al
    Image Gallery: Systemic sarcoidosis presenting within the black pigment of a cosmetic tattoo.
    Br J Dermatol. 2017;176:e2.
    PubMed     Text format    


  35. GORCZYZA M, Schoepke N, Krause K, Hawro T, et al
    Patients with chronic cold urticaria may benefit from doxycycline therapy.
    Br J Dermatol. 2017;176:259-261.
    PubMed     Text format    


  36. VOLKER-TOUW CM, de Koning HD, Giltay JC, de Kovel CG, et al
    Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype.
    Br J Dermatol. 2017;176:244-248.
    PubMed     Text format    


    December 2016
  37. ZHAO CY, Hao EY, Oh DD, Daniel BS, et al
    A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate to dark skin patients.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15271.
    PubMed     Text format     Abstract available


  38. BENSEFA-COLAS L, Stocks SJ, McNamee R, Faye S, et al
    Effectiveness of the European Chromium VI Directive for cement implementation on occupational allergic contact dermatitis occurrence: Assessment in France and UK.
    Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15261.
    PubMed     Text format     Abstract available


  39. NIC DHONNCHA E, Clowry J, Dunphy M, Buckley C, et al
    Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients.
    Br J Dermatol. 2016 Dec 22. doi: 10.1111/bjd.15262.
    PubMed     Text format     Abstract available


    November 2016
  40. ROEKEVISCH E, Leeflang MM, Schram ME, Campbell LE, et al
    Atopic dermatitis patients with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
    Br J Dermatol. 2016 Nov 19. doi: 10.1111/bjd.15191.
    PubMed     Text format     Abstract available


  41. BENNIKE NH, Zachariae C, Duus Johansen J
    Trends in contact allergy to fragrance mix I in consecutive Danish eczema patients over three decades; a cross-sectional study from 1986 to 2015.
    Br J Dermatol. 2016 Nov 18. doi: 10.1111/bjd.15180.
    PubMed     Text format     Abstract available


  42. GONZALEZ-LOPEZ G, Ceballos-Rodriguez RM, Gonzalez-Lopez JJ, Feito Rodriguez M, et al
    Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis.
    Br J Dermatol. 2016 Nov 8. doi: 10.1111/bjd.15165.
    PubMed     Text format     Abstract available


  43. KOPPES SA, Ljubojevic Hadzavdic S, Jakasa I, Franceschi N, et al
    Stratum corneum profiles of inflammatory mediators in patch test reactions to common contact allergens and sodium lauryl sulfate.
    Br J Dermatol. 2016 Nov 4. doi: 10.1111/bjd.15163.
    PubMed     Text format     Abstract available


  44. DAMSKY W, King BA
    STATing the obvious: it's time for new treatments in atopic dermatitis.
    Br J Dermatol. 2016;175:861-862.
    PubMed     Text format    


  45. EDWARDS C
    Measurements of structure and function of skin: emollient effects on atopic dermatitis.
    Br J Dermatol. 2016;175:868-869.
    PubMed     Text format    


  46. STROM MA, Fishbein AB, Paller AS, Silverberg JI, et al
    Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.
    Br J Dermatol. 2016;175:920-929.
    PubMed     Text format     Abstract available


  47. TAKEHARA A, Aoyama Y, Kurosawa M, Shirafuji Y, et al
    Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2016;175:944-952.
    PubMed     Text format     Abstract available


  48. TOMIDA E, Kato Y, Ozawa H, Hasegawa H, et al
    Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
    Br J Dermatol. 2016;175:1106-1108.
    PubMed     Text format    


    October 2016
  49. HEPBURN L, Hijnen DJ, Sellman BR, Mustelin T, et al
    The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.
    Br J Dermatol. 2016 Oct 25. doi: 10.1111/bjd.15139.
    PubMed     Text format     Abstract available


    September 2016
  50. HALLING-OVERGAARD AS, Kezic S, Jakasa I, Engebretsen KA, et al
    Skin absorption through atopic dermatitis skin: a systematic review.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15065.
    PubMed     Text format     Abstract available


  51. ORCIANI M, Campanati A, Caffarini M, Ganzetti G, et al
    Th1 -Th17 and Th2 imbalance in Mesenchymal Stem Cells of adult patients with atopic dermatitis: at the origin of the problem.
    Br J Dermatol. 2016 Sep 17. doi: 10.1111/bjd.15078.
    PubMed     Text format     Abstract available


    August 2016
  52. VENABLES ZC, Bourke JF, Buckley DA, Campbell F, et al
    Has the epidemic of allergic contact dermatitis due to Methylisothiazolinone reached its peak?
    Br J Dermatol. 2016 Aug 31. doi: 10.1111/bjd.15016.
    PubMed     Text format     Abstract available


  53. LEE UH, Kim BE, Kim DJ, Cho YG, et al
    Atopic dermatitis is associated with reduced corneodesmosin expression: role of cytokine modulation and effects on viral penetration.
    Br J Dermatol. 2016 Aug 30. doi: 10.1111/bjd.15010.
    PubMed     Text format     Abstract available


  54. MOSE KF, Andersen F, Skov L, Ropke MA, et al
    Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals.
    Br J Dermatol. 2016 Aug 12. doi: 10.1111/bjd.14949.
    PubMed     Text format     Abstract available


  55. KIM J, Han Y, Ahn JH, Kim SW, et al
    Airborne formaldehyde causes skin barrier dysfunction in atopic dermatitis.
    Br J Dermatol. 2016;175:357-63.
    PubMed     Text format     Abstract available


  56. WALSH S, Lew T, Lee HY
    Psychological sequelae of toxic epidermal necrolysis: further insights.
    Br J Dermatol. 2016;175:241.
    PubMed     Text format    


    July 2016
  57. BISSONNETTE R, Papp KA, Poulin Y, Gooderham M, et al
    Topical tofacitinib for atopic dermatitis: A Phase 2a randomised trial.
    Br J Dermatol. 2016 Jul 16. doi: 10.1111/bjd.14871.
    PubMed     Text format     Abstract available


  58. CHONG HT, Yang GN, Sidhu S, Ibbetson J, et al
    Reducing Flightless I expression decreases severity of psoriasis in an imiquimod-induced murine model of psoriasiform dermatitis.
    Br J Dermatol. 2016 Jul 4. doi: 10.1111/bjd.14842.
    PubMed     Text format     Abstract available


  59. MOLIN S
    Deciphering the lipidomic profile of irritant contact dermatitis.
    Br J Dermatol. 2016;175:20-1.
    PubMed     Text format    


    June 2016
  60. LYNCH MD, White JM, McFadden JP, Wang Y, et al
    A dynamic landscape of allergen associations in delayed-type cutaneous hypersensitivity.
    Br J Dermatol. 2016 Jun 10. doi: 10.1111/bjd.14793.
    PubMed     Text format     Abstract available


  61. CREAMER D, Walsh SA, Dziewulski P, Exton LS, et al
    U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Br J Dermatol. 2016;174:1194-227.
    PubMed     Text format    


  62. WOLKENSTEIN P, Wilson YT
    Toxic epidermal necrolysis: the past, the guidelines and challenges for the future.
    Br J Dermatol. 2016;174:1171-3.
    PubMed     Text format    


    May 2016
  63. PETRELLI F, Borgonovo K, Cabiddu M, Coinu A, et al
    Antibiotic prophylaxis for skin toxicity induced by anti-EGFR agents: a systematic review and meta-analysis.
    Br J Dermatol. 2016 May 23. doi: 10.1111/bjd.14756.
    PubMed     Text format     Abstract available


  64. PONGPAIROJ K, McFadden JP, Basketter DA
    Advice for patients with hair dye allergy remains 'stop using permanent hair dyes'.
    Br J Dermatol. 2016;174:957-8.
    PubMed     Text format    


  65. LAPI F, Cassano N, Pegoraro V, Cataldo N, et al
    Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy.
    Br J Dermatol. 2016;174:996-1004.
    PubMed     Text format     Abstract available


  66. ZIMMER S, Peveling-Oberhag A, Weber A, Gilfert T, et al
    Unique coexistence of cold and solar urticaria and its efficient treatment.
    Br J Dermatol. 2016;174:1150-2.
    PubMed     Text format    


  67. HAWKEY S, Abdul Ghaffar S
    Glove-related hand urticaria: an increasing occupational problem among healthcare workers.
    Br J Dermatol. 2016;174:1137-40.
    PubMed     Text format    


    April 2016
  68. SAWATKAR GU, Sahu KK, Prakash G, Dogra S, et al
    Image Gallery: Flagellate dermatitis.
    Br J Dermatol. 2016;174:e23.
    PubMed     Text format    


  69. PARISER DM, Eichenfield LF, Bukhalo M, Waterman G, et al
    Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
    Br J Dermatol. 2016;174:770-7.
    PubMed     Text format     Abstract available


  70. MAURER M, Staubach P, Raap U, Richter-Huhn G, et al
    ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice.
    Br J Dermatol. 2016;174:892-4.
    PubMed     Text format    


    March 2016
  71. CHON SY, Hassler AA
    Demodex inflammatory eruption due to epidermal growth factor receptor inhibitor therapy.
    Br J Dermatol. 2016;174:686-7.
    PubMed     Text format    


  72. BELLON T, Lerma V, Gonzalez-Valle O, Gonzalez Herrada C, et al
    Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds.
    Br J Dermatol. 2016;174:621-4.
    PubMed     Text format     Abstract available


  73. KURATA M, Horie C, Kano Y, Shiohara T, et al
    Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Br J Dermatol. 2016;174:681-3.
    PubMed     Text format    


  74. BENNETT MF, Lowney AC, Bourke JF
    A study of occupational contact dermatitis in the pharmaceutical industry.
    Br J Dermatol. 2016;174:654-6.
    PubMed     Text format    


  75. DAUNTON A, Bridgett C, Goulding JM
    Habit reversal for refractory atopic dermatitis: a review.
    Br J Dermatol. 2016;174:657-9.
    PubMed     Text format    


    February 2016
  76. HASHIMOTO T, Ohzono A, Ishii N
    'Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus': reply from the authors.
    Br J Dermatol. 2016;174:461-2.
    PubMed     Text format    


  77. AMBER KT
    Reply to: Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.
    Br J Dermatol. 2016;174:461.
    PubMed     Text format    


  78. BROWN SJ
    Hand dermatitis in construction workers: a lesson in genetic epidemiology.
    Br J Dermatol. 2016;174:263-5.
    PubMed     Text format    


  79. HAUKSSON I, Ponten A, Gruvberger B, Isaksson M, et al
    Skincare products containing low concentrations of formaldehyde detected by the chromotropic acid method cannot be safely used in formaldehyde-allergic patients.
    Br J Dermatol. 2016;174:371-9.
    PubMed     Text format     Abstract available


  80. TIMMERMAN JG, Heederik D, Spee T, van Rooy FG, et al
    Contact dermatitis in the construction industry: the role of filaggrin loss-of-function mutations.
    Br J Dermatol. 2016;174:348-55.
    PubMed     Text format     Abstract available


  81. NEMOTO O, Furue M, Nakagawa H, Shiramoto M, et al
    The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placeb
    Br J Dermatol. 2016;174:296-304.
    PubMed     Text format     Abstract available


  82. DIEPGEN TL, Ofenloch RF, Bruze M, Bertuccio P, et al
    Prevalence of contact allergy in the general population in different European regions.
    Br J Dermatol. 2016;174:319-29.
    PubMed     Text format     Abstract available


  83. STINGENI L, Bianchi L, Tramontana M, Moretta I, et al
    Indoor dermatitis due to Aeroglyphus robustus.
    Br J Dermatol. 2016;174:454-6.
    PubMed     Text format    


  84. SCHLIPF NA, Vahlquist A, Teigen N, Virtanen M, et al
    Whole-exome sequencing identifies novel autosomal recessive DSG1 mutations associated with mild SAM syndrome.
    Br J Dermatol. 2016;174:444-8.
    PubMed     Text format    


    January 2016
  85. LIN CH, Wei CC, Lin CL, Lin WC, et al
    Childhood type 1 diabetes may increase the risk of atopic dermatitis.
    Br J Dermatol. 2016;174:88-94.
    PubMed     Text format     Abstract available


  86. TSUTSUMI M, Kitahata H, Fukuda M, Kumamoto J, et al
    Numerical and comparative three-dimensional structural analysis of peripheral nerve fibres in epidermis of patients with atopic dermatitis.
    Br J Dermatol. 2016;174:191-4.
    PubMed     Text format    


  87. POLITIEK K, van der Schaft J, Coenraads PJ, de Bruin-Weller MS, et al
    Drug survival for methotrexate in a daily practice cohort of adult patients with severe atopic dermatitis.
    Br J Dermatol. 2016;174:201-3.
    PubMed     Text format    


    November 2015
  88. VINTER H, Kragballe K, Steiniche T, Gaestel M, et al
    TNFalpha plays a significant role in the Aldara-induced skin inflammation in mice.
    Br J Dermatol. 2015 Nov 28. doi: 10.1111/bjd.14320.
    PubMed     Text format     Abstract available


    September 2015
  89. CARRASCOSA R, Llamas-Velasco M, Montes-Torres A, Sanchez-Perez J, et al
    Does boceprevir really increase the risk of skin eruptions during antihepatitis C treatment?
    Br J Dermatol. 2015 Sep 15. doi: 10.1111/bjd.14169.
    PubMed     Text format     Abstract available


    July 2015
  90. WU J, Lee YY, Su SC, Wu TS, et al
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in patients with malignancies.
    Br J Dermatol. 2015 Jul 27. doi: 10.1111/bjd.14052.
    PubMed     Text format     Abstract available


    June 2015
  91. MALERBA M, Damiani G, Radaeli A, Ragnoli B, et al
    Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma.
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13988.
    PubMed     Text format     Abstract available


  92. PIRMEZ R, Fernandes AL, Melo MG
    Photoaggravated contact dermatitis to Kathon CG (methylchloroisothiazolinone/methylisothiazolinone): a novel pattern of involvement in a growing epidemic?
    Br J Dermatol. 2015 Jun 30. doi: 10.1111/bjd.13986.
    PubMed     Text format     Abstract available


  93. SINHA R, Larkin J, Gore M, Fearfield L, et al
    Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF mutation-positive metastatic melanoma, including recognition and management of rare presentations.
    Br J Dermatol. 2015 Jun 24. doi: 10.1111/bjd.13958.
    PubMed     Text format     Abstract available


    April 2015
  94. DE KONING HD, van Vlijmen-Willems IM, Rodijk-Olthuis D, van der Meer JW, et al
    Mast cell interleukin-1 beta, neutrophil interleukin-17 and epidermal antimicrobial proteins in the neutrophilic urticarial dermatosis in Schnitzler's syndrome.
    Br J Dermatol. 2015 Apr 22. doi: 10.1111/bjd.13857.
    PubMed     Text format     Abstract available


    March 2015
  95. ALLOO A, Sheu J, Butrynski JE, DeAngelo DJ, et al
    Ponatinib-Induced Pityriasiform, Folliculocentric and Ichthyosiform Cutaneous Toxicities.
    Br J Dermatol. 2015 Mar 4. doi: 10.1111/bjd.13692.
    PubMed     Text format     Abstract available


  96. CHENG L, Xiong Y, Qin CZ, Zhang W, et al
    HLA-B*58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study.
    Br J Dermatol. 2015 Mar 2. doi: 10.1111/bjd.13688.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: